Advertisement
Formulation/Delivery
Subscribe to Formulation/Delivery

The Lead

Roche Launches Next-Generation HBV Viral Load Assay in Select Markets

March 3, 2015 9:09 am | News | Comments

The new assay offers broad coverage of all known Hepatitis B (HBV) genotypes (A-H) with high sensitivity, across all critical medical decision points. Read more...                

New Nanodevice Defeats Drug Resistance

March 3, 2015 8:46 am | by Anne Trafton, MIT | News | Comments

Chemotherapy often shrinks tumors at first, but as cancer cells become resistant to drug...

Takeda's Treatment for Acid-Related Diseases is Now Available in Japan

February 27, 2015 9:10 am | News | Comments

This medicine treats acid-related diseases with a novel mechanism of action called potassium-...

Synthetic Biology Breakthrough Leads to Cheaper Statin Production

February 27, 2015 8:33 am | by University of Manchester | News | Comments

Researchers have devised a single-step fermentative method for the industrial production of the...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Scientists Develop Method to Suppress Malaria Parasite's Virulence Genes

February 26, 2015 8:41 am | by Hebrew University | News | Comments

Researchers have revealed the genetic trickery this deadly parasite deploys to escape attack by the human immune system. Read more...                     

Warning on Use of Drug for Children's Sleep

February 25, 2015 4:39 pm | by University of Adelaide | News | Comments

Researchers are warning doctors and parents not to provide the drug melatonin to children to help control their sleep problems. Read more...                    

Malaria: Down But Not Out

February 25, 2015 3:22 pm | by Alvin Powell, Harvard Staff Writer | News | Comments

Disease has been resilient and efforts to eradicate it require a local focus. Read more...                            

Advertisement

New Polio Vaccine Gets Funding for Development, Trail

February 25, 2015 10:29 am | by Georgia Institute of Technology | News | Comments

The Georgia Institute of Technology and Micron Biomedical have been awarded $2.5 million in grants from the Bill & Melinda Gates Foundation to advance the development of dissolvable microneedle patches for polio immunization. Read more...

Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Hepatitis C Medication in India

February 23, 2015 9:24 am | News | Comments

The drugs, Harvoni and Solvadi, are expected to arrive in the second quarter of 2015. Read more...                           

Large Amounts of Mitochondrial Toxic Agents Cross the Placenta Barrier

February 20, 2015 9:07 am | by Hospital Clinic of Barcelona | News | Comments

Mitochondria can suffer from two types of disease: genetic or acquired. Read more...                             

The Journey to an HIV Vaccine Endures

February 19, 2015 12:46 pm | by Stephanie Guzowski, Editor | Articles | Comments

Despite more than 30 years of efforts, scientists have not yet come up with a reliably effective HIV vaccine — in part, because of the inherently complicated nature of the virus. Here are where their research efforts stand today.

New Nanogel for Drug Delivery

February 19, 2015 9:39 am | by MIT | News | Comments

Scientists are interested in using gels to deliver drugs because they can be molded into specific shapes and designed to release their payload over a specified time period. However, current versions aren’t always practical because must be implanted surgically. Read more...

Advertisement

In Pakistan, Vaccinating Children Has Become a Deadly Battle

February 18, 2015 8:38 am | by Rebecca Santana, Associated Press | News | Comments

While vaccine distrust has sparked debates amid a measles outbreak in the United States, Pakistan is in a deadly battle to wipe out polio. Read more...                  

Engineered Insulin Could Offer Better Diabetes Control

February 10, 2015 11:58 am | by Anne Trafton, MIT | News | Comments

Engineers hope to improve treatment for diabetes patients with a new type of engineered insulin. Read more...                         

Engineered Insulin Could Offer Better Diabetes Control

February 10, 2015 11:58 am | by Anne Trafton, MIT | News | Comments

Engineers hope to improve treatment for diabetes patients with a new type of engineered insulin. Read more...                         

FDA Accepts Actavis' sNDA for Teflaro Labeling Expansion

February 5, 2015 4:03 pm | News | Comments

The FDA has set a target of Q3 2015 to complete its review of the medication. Read more...                             

Water Street Invests in Generic Injectable Drug Services Company

February 4, 2015 11:33 am | News | Comments

Water Street's new invesment specializes in generic injectable product development and regulatory consulting services. Read more...                      

Advertisement

Sanofi, Mannkind Announce Inhaled Insulin Afrezza Availability in U.S.

February 3, 2015 4:04 pm | News | Comments

Afrezza is approved by the U.S. Food and Drug Administration to control high blood sugar in adults with type 1 and type 2 diabetes. Read more...                    

Astellas, Immunomic Therapeutics Announce Licensing Agreement for Allergy Vaccine

January 30, 2015 9:32 am | News | Comments

The vaccine is designed to treat allergies induced by Japanese red cedar pollen. Read more...                            

Amgen Submits Application in U.S. and Europe for Multiple Myeloma Treatment

January 28, 2015 9:05 am | News | Comments

The drug is an injection that can treat patients with relapsed multiple myeloma who have received at least one prior therapy. Read more...                     

Have Faith in the Flu Shot

January 23, 2015 1:01 pm | by Chris DeFrancesco, University of Connecticut | News | Comments

The rate of effectiveness for this year’s vaccine has been disappointing, with at least half the states reporting widespread incidence of influenza. Read more...                 

Progress in Diabetes Drug Delivery

January 23, 2015 9:23 am | by Rebecca Graham, Science Network WA | News | Comments

A DRUG therapy for diabetes treatment is being developed by an international research team led by WA scientists, which combines an existing anti-diabetic drug with bile acids to improve the drug's delivery and prolong release. Read more...                 

Long-Awaited Ebola Vaccine Study Coming Soon in Liberia: U.S.

January 23, 2015 9:12 am | by Lauren Neergaard, AP Medical writer - Associated Press | News | Comments

Long-awaited studies of two possible Ebola vaccines are set to begin in West Africa in a couple of weeks, starting in Liberia, U.S. officials said. Read more...                                 

Sanofi, BI Enter Manufacturing Collaboration for Biologics

January 16, 2015 8:48 am | News | Comments

72 percent of Sanofi’s Research and Development projects are in biologics, nearly half of which are monoclonal antibodies (mAbs). Read more...                    

CDC: Flu Vaccine Not Working Well

January 15, 2015 2:07 pm | by Mike Stobbe - AP Medical Writer | News | Comments

The CDC's report explains that this year's vaccine is only 23 percent effective. Read more...                            

'Molecular Truck' Could Deliver New Treatment

January 15, 2015 10:20 am | by Darci Slaten, University of Arizona | News | Comments

University of Arizona researchers have developed a novel drug and delivery system to treat inflammation and ulcerations in the colon. Read more...                                            

FDA Approves First of Kind Device for Obesity Treatment

January 14, 2015 12:44 pm | News | Comments

This is the first weight loss treatment device that targets the nerve pathway between the brain and the stomach that controls feelings of hunger and fullness. Read more...              

Daiichi Sankyo's AFib Tablets Gain FDA Approval

January 9, 2015 9:36 am | News | Comments

The tablets reduce the risk of stroke and systemic embolism. Read more...                               

'Cellular Backpacks' Attach to White Blood Cells Targeting Inflammation

January 8, 2015 12:52 pm | by University of California, Santa Barbara | News | Comments

Persistent inflammation is often indicative of more serious conditions and can lead to problems of its own, including impaired healing, loss of function or even tissue death. Read more...            

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading